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The adult central nervous system (CNS) contains resident stem cells within specific
niches that maintain a self-renewal and proliferative capacity to generate new
neurons, astrocytes, and oligodendrocytes throughout adulthood. Physiological aging
is associated with a progressive loss of function and a decline in the self-renewal
and regenerative capacities of CNS stem cells. Also, the biggest risk factor for
neurodegenerative diseases is age, and current in vivo and in vitro models of
neurodegenerative diseases rarely consider this. Therefore, combining both aging
research and appropriate interrogation of animal disease models towards the
understanding of the disease and age-related stem cell failure is imperative to the
discovery of new therapies. This review article will highlight the main intrinsic and extrinsic
regulators of neural stem cell (NSC) aging and discuss how these factors impact normal
homeostatic functions within the adult brain. We will consider established in vivo animal
and in vitro human disease model systems, and then discuss the current and future
trajectories of novel senotherapeutics that target aging NSCs to ameliorate brain disease.
Keywords: neural stem cells, aging, senescence, cell metabolism, mitochondria, disease modeling,
senotherapeutics
INTRODUCTION
Aging is defined as the time-related decline of physiological functions that are necessary for survival
eventually leading to the cessation of life (Harman, 2001; López-Otín et al., 2013). The general
characteristics of aging, such as cognitive decline, cardiovascular defects, and metabolic changes
affect all individuals at varying rates. While some endure aging in a healthy manner, defined as
healthy aging, others age unhealthily, developing age-related disorders such as cardiovascular
disease, cancer, Alzheimer’s disease (AD), and diabetes (Chang et al., 2019; Cole et al., 2019).
Genetic and environmental factors, such as smoking, exercise, and diet, impart significant
alterations to normal physiology that define the rate an organism ages (Harman, 2001). This
implies that though two people are the same chronological age their biological brain age may be
significantly different (Franke and Gaser, 2019).
Measures have been developed and refined over the preceding decade to assay human
brain age in vivo, including MRI to both measure gray matter volume and alterations
in neural activity. The results from these studies, with due consideration to all caveats
and limitations, have demonstrated that a ‘‘brain age’’ can be computed, establishing a
novel idea of a ‘‘brain age gap.’’ The ‘‘brain age gap’’ is defined as the gap between a
person’s chronological age and their biological brain age based on a pre-determined set
of MRI criteria. This computational approach establishes how healthy or unhealthy an
individual’s brain age is and this data can then be extrapolated to then anticipate risk in the
development of age-associated brain diseases and can be extended to anticipate the risk of
developing age-associated brain diseases (Cole and Franke, 2017). For example, dementia/AD
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and multiple sclerosis (MS) exhibit the strongest discordance
between actual chronological age and predicted age using an
unbiased machine MRI learning tool (Kaufmann et al., 2019).
Typically, the effects of advancing chronological age, including
cognitive decline, become significantly apparent between the
ages of 60–75 years as evidenced by the significant loss of
total tissue volume, which coincides with the peak onset of
age-associated neurodegenerative diseases (Scahill et al., 2003;
Chad et al., 2018; Franceschi et al., 2018). These diseases
can also occur earlier in life in subjects with higher genetic
and environmental risk factors, which suggests an accelerated
aging phenotype may play a role. Similar deficits in cognitive
function correlated with changes in brain volume are observed
in aged humans and rodents (20–24 months old), making them
a valuable model (Hamezah et al., 2017). Furthermore, most
of these morphological changes are correlated with increased
synaptic dysfunction, which leads to the gain-of-function of
behavioral deficits observed in aging, such as cognitive decline,
learning, memory, and sensory deficits (Petralia et al., 2014).
Both human and rodent work has suggested a correlation
between a decrease in the number of synaptic connections and
an increase age-related cognitive decline (Dickson et al., 1995;
Peters et al., 2008). The predominant hallmark used to compute
biological age in humans is brain volume, which is associated
with a decrease in synaptic connections, suggesting a lack of
renewal, replacement, and regeneration on a cellular level.
Neural stem cells (NSCs) persist throughout mammalian
life, residing within the subgranular zone (SGZ) of the
hippocampus and the subventricular zone (SVZ) of the
lateral ventricles, where they maintain the capacity for
self-renewal and maturation into new neurons and glia.
NSCs are mitotic cells characterized by symmetric divisions
(self-renewal) during early development. They gradually
shift to asymmetrical division to generate differentiated
cells and maintain a multipotent reservoir (Gage, 2000;
Alvarez-Buylla and Lim, 2004; Zhao et al., 2008; Gage
and Temple, 2013; Obernier and Alvarez-Buylla, 2019).
Although the proliferation and differentiation of NSCs
are predominantly restricted to the embryonic period in
rodents, the capacity to produce new neurons has been
shown to persist into adulthood, however, whether this is
an evolutionarily conserved process in humans remains
controversial (Sorrells et al., 2018; Moreno-Jiménez et al.,
2019). Evidence for neurogenesis in healthy adult humans
is provided by the presence of NSCs and immature neurons
both expressing cell division markers (Moreno-Jiménez
et al., 2019; Tobin et al., 2019). Also, neurogenesis has
been reported using radioactive carbon-based cell dating
and BrdU incorporation studies (Eriksson et al., 1998;
Spalding et al., 2013). These dynamics in humans have been
observed to change with disease, such as AD, where immature
neurons are found greatly reduced, and MS, where NSCs are
found increased in the SVZ (Nait-Oumesmar et al., 2007;
Moreno-Jiménez et al., 2019).
In adult mice, NSCs residing within the specialized niches
are known to play important roles in maintaining cognitive
functions, such as learning and memory formation, and
contributing to repair and regeneration of injured tissue, which
includes their neurogenic capability (Imayoshi et al., 2008;
Lugert et al., 2010). These new neurons contribute to learned
behavior such as odor reward association and discrimination
(Grelat et al., 2018; Li et al., 2018). Advancing age-related
biological changes are associated with a significant decline in
neurogenesis, concomitant with dynamic alterations to the niche
microenvironment that disrupt normal homeostatic functions
(Kuhn et al., 1996).
Several tissues and cell-based biological biomarkers have been
identified that reflect age-related processes, such as senescent
cell burden, genomic instability, on-going chronic inflammation,
and telomere attrition (Figure 1; López-Otín et al., 2013). The
accumulated burden of aging defects contributes to overall brain
degeneration, drastically impacting the regenerative potential
of the NSC niches. Also, ongoing disease burden has been
shown to accelerate biological brain aging in AD/dementia,
PD, amyotrophic lateral sclerosis (ALS), MS, and Huntington’s
disease (HD), all neurodegenerative diseases with demonstrated
dysfunction in NSC compartments (Horgusluoglu et al., 2017;
Hou et al., 2019).
In this review article, we will highlight how intrinsic, as well
as extrinsic regulators of age and disease, impart drastic changes
to the endogenous NSC niche, how this is modeled in vitro and
in vivo, and new therapies on the horizon targeted at aging NSCs
to ameliorate brain disease.
BRAIN STEM CELL NICHES IN AGING AND
DISEASE
Mammalian NSCs within niches adopt various states including
quiescence, activation, and differentiation, however, the
proportions of cells in those states change dramatically with
increasing biological age (Obernier and Alvarez-Buylla, 2019). A
large body of evidence has revealed that aging negatively impacts
these niches, ultimately impacting regenerative functions. One
major component being cellular senescence, which is a process
in which cells experience a decrease in their proliferative capacity
and undergo profound alterations which inherently changes their
normal functions, impacting surrounding cells, and eventually
leading to age-associated organ dysfunction (Baker and
Petersen, 2018). Senescent cells accumulate with age and impact
regeneration and homeostatic functions within stem cell niches,
and experimental evidence in mice has linked the elimination of
these cells to an increase in lifespan and a delay in age-associated
disorders (Baker et al., 2011; Yousefzadeh et al., 2020). They
disturb the microenvironment by secreting a wide-range of
factors, including pro-inflammatory proteins, chemokines,
and interleukins (ILs) which have a profound effect on other
cells around them, termed the senescence-associated secretory
phenotype (SASP; Coppé et al., 2010; Angelova and Brown, 2019;
Cohen and Torres, 2019). Senescent cells have been identified
in the aging brain of both humans and rodents, particularly in
the context of neurodegenerative disease (Baker and Petersen,
2018). Senescence is initiated by a myriad of aging-related
factors, both intrinsic and extrinsic, which will be reviewed in
this section.
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FIGURE 1 | Intrinsic and extrinsic regulators of NSC aging. Intrinsic regulators include transcriptional changes, such as upregulation of p16Ink4a and p53;
mitochondrial damage, resulting from mtDNA mutations and excessive ROS; toxic protein aggregates, due to a dysregulation in proteostasis; SA-β-gal expression,
induced by senescence; telomere shortening and DNA damage caused by replication-associated stress and dysfunctional repair amongst other factors; and
changes in epigenetic patterns. Extrinsic regulators include SASP, secreted by nearby senescent cells, and secreted by senescent NSCs themselves; modifications
in ECM, such as increases in HA composition; and inflammatory molecules secreted by activated astrocytes, microglia, and T-cells. Abbreviations: ECM, extracellular
matrix; HA, hyaluronic acid; mtDNA, mitochondrial DNA; NSC, neural stem cells; ROS, reactive oxygen species; SASP, senescence-associated secretory phenotype.
DNA Damage and Repair
Several studies have demonstrated that chronological aging
results in the increased accumulation of DNA damage in tissues
and cells (Kenyon, 2010; Sperka et al., 2012). For example,
replication-associated DNA damage leads to mutations and
increases genomic instability with advancing age (Adams et al.,
2015). In line with this observation, NSCs isolated from the
SVZ of 20-month old-aged mice displayed significant genetic
aberrations compared to NSCs isolated from 2-month old
mice, which is attributed to the increased accumulation of
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mutations over replicative cycles (Bailey et al., 2004). NSCs
avoid replication stress by entering an inactive stage called
quiescence, highlighted by a low basal metabolic rate and
limited self-renewal. Following disease or tissue damage, reactive
oxygen species (ROS) production stimulates adult NSCs to
re-enter the cell cycle to replenish damaged and dying cells.
Coincidentally, this results in replication-induced stress and an
increased frequency of DNA mutations (Wang Y. Z. et al.,
2011). This highlights the importance of maintaining a proper
balance between quiescence and activation within NSC niches to
minimize replicative stress and maximize DNA integrity during
chronological and biological aging.
Genomic instability with advancing age is thought to be the
result of increased accumulation of DNA damage in tandemwith
a diminished DNA damage response. It has been reported that
NSCs fail to proliferate and undergo appropriate differentiation
in the absence of functional DNA repair mechanisms (Figure 2;
Marin Navarro et al., 2020). Under normal non-aged conditions
cells still face genotoxic insults from endogenous by-products
such as ROS, inflammatory mediators, and lipid peroxidation
while maintaining DNA damage response and repair processes
(Mani et al., 2020). This includes the five major repair pathways,
base excision repair (BER), nucleotide excision repair (NER),
mismatch repair (MMR), homologous recombination (HR),
and non-homologous end joining (NHEJ), which all involve
a complex interplay of genes and their ensuing proteins.
These pathways attempt to repair the lesioned area, however,
breakdowns in signaling activate apoptotic mechanisms to
inhibit the propagation of the lesioned DNA (Petr et al.,
2020). The efficiency in these processes declines with age for
reasons that remain unclear leading to a build-up of DNA
damage. Evidence points to transcriptional repression of DNA
repair genes in aging cells as well as age-related decreases
in repair enzymes and activities accounting for the increased
DNA damage with age (Szczesny et al., 2003; Imam et al.,
2006; Collin et al., 2018). Additionally, DNA damage response
elements such as NER, BER, MMR, and NHEJ are important
in the maintenance of the NSC niche with defective elements
associated with age-related neurodegenerative diseases such as
ALS, AD, and PD (Liu and Martin, 2006; Sepe et al., 2016;
Shanbhag et al., 2019).
Retrotransposable elements (RTEs) are DNA elements that
have been copied and pasted from one location to another and
can also give rise to genomic instability through mutations and
double-strand breaks which in turn impacts gene regulation
(Terry and Devine, 2019). Further, increased activity of RTEs
has been observed in the aged human brain and results in
genome instability in NSCs (Bollati et al., 2009; Maxwell et al.,
2011). One example being long interspersed nuclear element-1
(LINE-1), which is normally repressed by Sox2, a gene required
for the maintenance of NSCs with diminished expression in
the hippocampal SGZ with advancing age (Muotri et al., 2005;
Carrasco-Garcia et al., 2019). Decreased expression of Sox2
within the hippocampal SGZ in aged mice is inversely correlated
with the increased expression of the cyclin-dependent kinase
inhibitor p16Ink4a, an established biomarker of senescent cells
(Carrasco-Garcia et al., 2019). Specifically, LINE-1 becomes
transcriptionally derepressed in p16Ink4a expressing cells, which
triggers a type-I interferon (IFN-1) response and initiates
the secretion of pro-inflammatory cytokines, proteases, and
immune modulators inhibiting NSC proliferation and leading
to age-associated chronic inflammation (Coppé et al., 2010;
Kulkarni et al., 2017; De Cecco et al., 2019).
Genomic instability can also result from telomere shortening,
one of the major mechanisms proposed to induce organismal
aging (López-Otín et al., 2013). Telomeres are specialized
structures that cap the ends of chromosomes protecting from
gene erosion and fusion with neighboring chromosomes (Sahin
and Depinho, 2010). In humans, the average telomere length
declines in advancing age due to truncation occurring following
a lifetime of cell division, with the endogenous enzyme
telomerase maintaining telomere length to protect against
genomic instability and intrinsic DNA damage (Arai et al., 2015).
Importantly, adult NSCs within the rodent SVZ are known
to have high telomerase activity to meet the proliferative and
self-renewal needs of the cell (Caporaso et al., 2003), however
telomerase in isolation cannot maintain telomere length within
NSC niches. In fact, the deleterious effects of shortened telomeres
in NSCs are mediated, in part, by p53, a tumor suppressor
protein and potential biomarker of aging and senescence with
increased expression in aged tissues (Rodier et al., 2007). Mutant
mice overexpressing p53 have a reduction in NSC proliferation,
highlighting a role for p53 in the aging NSC niche (Medrano
et al., 2009). When considered together, this work underscores
the importance of genomic stability in the maintenance and
proper functioning of adult NSCs (Figure 2).
Intrinsic Regulators
The frequency of intrinsic regulators of DNA damage increases
with advancing age, negatively influencing the expression
of regulatory genes important for homeostasis (Figure 2;
Espada and Ermolaeva, 2016). For example, members of
the forkhead box transcription factor family O (FoxO)
are indispensable in maintaining NSC proliferation and
self-renewal throughout adulthood by regulating a program
of genes that controls quiescence, differentiation, and oxygen
metabolism (Paik et al., 2009; Renault et al., 2009). Constitutive
knock-out of Foxo3 in mice reduces the total NSC pool
and leads to decreased self-renewal and impaired ability
to generate different neural lineages (Renault et al., 2009).
Supporting this notion, diminished regulatory gene expression
either indirectly or directly underlies NSC dysfunction in
advancing age. A follow-up study identified an alternative
function of Foxo3 in directly regulating autophagy genes in
NSCs with its loss leading to the accumulation of protein
aggregates and resultant homeostatic dysfunction (Audesse
et al., 2019). This is of particular importance as protein
aggregation is a key histological hallmark in many age-related
neurodegenerative diseases, such as the accumulation of
amyloid-β (Aβ) and tau tangles in AD and alpha-synuclein
deposits in PD. Foxo3 remains an attractive target for
further functional studies and therapeutic targeting as
genome-wide association studies have identified a single-
nucleotide polymorphism (SNP) within the FOXO3 gene that
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FIGURE 2 | Hallmarks and phenotype of NSC aging. The main phenotypes, hallmarks, and models that can be used to investigate aspects of NSC aging. Genomic
instability, metabolic dysfunction, inflammaging, and senescence are all aspects that affect the normal proliferation and differentiation function of NSCs. These causes
of aging have specific hallmarks that can be identified using in vivo and in vitro methods. Abbreviations: CSF, cerebrospinal fluid; iPSC, induced pluripotent stem cell;
mtDNA, mitochondrial DNA; NSC, neural stem cell; OPC, oligodendrocyte progenitor cell; OXPHOS, oxidative phosphorylation; PPMS, primary progressive multiple
sclerosis; ROS, reactive oxygen species; SA-β-gal, senescence-associated β-galactosidase; SASP, senescence-associated secretory phenotype.
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is associated with extreme longevity in humans (Willcox et al.,
2008; Flachsbart et al., 2009).
Intrinsic DNA damage also occurs in mitochondrial
(mt)DNA. A higher incidence of mtDNA mutations is known to
be associated with physiological brain aging and in age-related
neurodegenerative diseases such as AD and PD (Zapico and
Ubelaker, 2013; Cha et al., 2015). Somatic mtDNA mutations
accumulate in all tissues with age in a stochastic manner
(Chinnery et al., 2002; Bratic and Larsson, 2013). It is still
unclear why somatic mutations in mtDNA increase with
age, but most evidence points to increased pro-inflammatory
insults (Larsson, 2010). An alternative hypothesis implicates
replication errors that occur during embryogenesis which
undergo expansion in adult life and accumulate (Larsson, 2010).
Therefore, further studies investigating the cause of mtDNA
mutations in aging are warranted.
Once an arbitrary threshold is surpassed, where the levels
of accumulated mtDNA mutations surpass normal/healthy
mtDNA, energy metabolism is impaired (Figure 2; Wallace,
2010). This is significant in tissues with high energy demands
such as the NSC niches of the developing and injured adult
brain (Cavallucci et al., 2016). mtDNA integrity is maintained
via repair machinery such as 8-oxoguanine DNA glycosylase
(OGG1), a DNA repair protein that restores damaged mtDNA.
This repair machinery is important in maintaining NSC
multipotency as evidenced in NSCs from Ogg1 knockout-mice
which spontaneously accumulate mtDNA damage, shifting their
differentiation pattern towards an astrocytic lineage vs. neuronal
(Wang W. et al., 2011). Further, two separate reports have
identified a decrease in human OGG1 activity in the AD
brain (Mao et al., 2007; Jacob et al., 2013). mtDNA is also
susceptible to damage due to a lack of histone protection
and proximity to ROS generated by mitochondria (Alexeyev
et al., 2013). An overabundance of ROS in NSC niches impairs
adult neurogenesis (Rola et al., 2007). The accumulation of
mtDNA mutations over time results in respiration deficiency
and the further, excessive production of ROS (Murphy, 2009).
Mitochondrial ROS act as regulators to facilitate gene expression
changes that impact NSC fate decisions (Maryanovich and
Gross, 2013). Ablating the mitochondrial transcription factor A
(Tfam) in mice produces histological and pathological hallmarks
of aging in the hippocampus of mice, including impaired
proliferation and neurogenesis in NSCs (Beckervordersandforth
et al., 2017a). Interestingly, reductions in the TFAM gene
and protein expression are observed in advancing age and
age-associated neurodegenerative diseases such as PD, AD, and
HD (Kang et al., 2018). Overall, these studies point to the natural
accumulation of mtDNA mutations in normal aging, which
may be accelerated in neurodegenerative disorders, leading to
widespread NSC dysfunction.
Epigenetics
Epigenetic modifications naturally occur and accumulate with
age resulting in long-lasting functional changes to cells and
tissues (Figure 1). These modifications are attributed to
cell-intrinsic and extrinsic factors inherited through subsequent
cell divisions (Feil and Fraga, 2012; Podobinska et al., 2017).
An example of this is histone acetylation and deacetylation,
which is regulated by histone acetyltransferase (HAT) and
deacetylase (HDAC) enzymes, respectively. Acetylation of
histones relaxes the chromatin structure increasing accessibility
to the gene for transcription. In aged mice, an imbalance in
the acetylation and deacetylation of genes in the hippocampus
is correlated with memory impairment (Peleg et al., 2010).
Epigenetic modifications also occur through DNA methylation,
a crucial process regulating and controlling gene expression
by various DNA methyltransferases (DNMTs). Changes in the
DNA methylation status are observed in the brain of human
post-mortem subjects with advanced age (Numata et al., 2012).
Interestingly, the biological aging of tissue correlates with
patterns in DNA methylation termed the ‘‘epigenetic clock’’
(Horvath et al., 2012). Tet methylcytosine dioxygenase 2 (TET2),
a regulator of DNA methylation, is reduced in human aging
and somatic mutations are associated with an elevated risk of
developing age-related disorders such as stroke (Burgess, 2015).
Similarly, Tet2 expression is reduced in NSCs from aged rodents
with complete ablation inhibiting normal neurogenesis (Gontier
et al., 2018). Many different epigenetic factors are known to
alter adult NSC renewal and differentiation capacity, such as
mixed-lineage leukemia 1 (Mll1), a chromatin remodeling factor
identified inmice, yet their role in age and age-associated diseases
remain to be elucidated (Lim et al., 2009).
Nucleoporins (Nups) are a family of proteins that form
channels within the nuclear envelope, thus regulating the flow
of macromolecules, and have emerged as epigenetic regulators of
NSC differentiation (Raices and D’Angelo, 2017). Differentiation
of NSCs is accompanied by changes in nuclear reorganization
which result in gene expression changes mediated by Nup
expression (Capelson et al., 2010). Furthermore, Nups physically
interact with the genome to control transcriptional programs.
In NSCs, NUP153 is essential for maintaining stemness via its
complex with the transcription factor Sox2. In turn, the silencing
of Nup53 results in neuronal differentiation, associated with a
loss of Sox2 expression (Toda et al., 2017). NUP153 has also
been implicated in age-related diseases, such as AD (Sakuma
and D’Angelo, 2017; Leone et al., 2019). In NSCs isolated
from the 3xTg-AD mouse model, Nup153 expression was
significantly reduced, inhibiting proliferation, migration, and
neuronal differentiation. Instead, Nup153 overexpression in
AD NSCs rescued defective proliferation and migration and
enhanced neuronal differentiation. Thus, Nup153 acts as an
epigenetic hub for a variety of co-regulators (Leone et al.,
2019). Different outcomes in NSC differentiation associated
with Nup153 expression may also be context dependent and
in turn change the epigenetic behavior of Nup153. A further
understanding in how Nups alter NSC behavior in aging and
disease is warranted.
Cell Metabolism
The metabolism of stem cells plays a vital role in maintaining
cellular homeostasis through the regulation of various processes,
such as the generation of energy and proteins along with
the breakdown and elimination of waste. Changes in the
balance of these functions alter NSC behavior, especially the
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propensity to proliferate and differentiate (Figure 2). Many
of these basic homeostatic functions, such as mitochondrial
maintenance, proteostasis, and nutrient sensing, are altered
with age and considered hallmarks of aging (López-Otín et al.,
2013). Rapamycin, a drug that targets the mammalian target
of rapamycin (mTOR) pathway, which is critical to cellular
metabolism, has been identified to prolong rodent lifespan,
further elucidating the importance of cellular metabolism in
aging (Harrison et al., 2009). Probing the mechanisms by which
aging alters the variety of metabolic aspects is important in the
discovery of new avenues for therapeutic targeting.
Considerable activity into understanding the biological
processes that modify NSC metabolism in advancing age
have demonstrated the importance of proteostasis, or
protein homeostasis, in maintaining cellular health. During
advancing age, breakpoints in proteostasis result in the
accumulation of misfolded proteins and associated cellular
damage and dysfunction (Figure 1; Koga et al., 2011). Several
neurodegenerative diseases are identified by the accumulation
of misfolded and damaged proteins, such as Aβ in AD, alpha-
synuclein deposits in PD, and Lewy bodies in dementia, which
are known to negatively affect NSC niches (Basaiawmoit and
Rattan, 2010). NSCs from aged mice have been shown to
accumulate protein aggregates in defective lysosomes, limiting
normal digestion and removal in quiescent NSCs of aged
rodents. Lysosomal dysfunction, and in turn accumulation
of insoluble protein aggregates, prevented quiescent NSCs
from aged animals to return to an activated, proliferative state.
Enhancing lysosomal function through transcription factor EB
(TFEB) activity, a master regulator of lysosomes restores NSC
activation ability (Leeman et al., 2018). A functional outcome
of damaged protein accumulation in NSCs with advancing
age is a weakening of the diffusion barrier which maintains
the distribution of cellular components during replication
or differentiation. This prevents asymmetric segregation of
damaged proteins and further propagates the accumulation
of misfolded proteins in daughter cells (Moore et al., 2015).
Also, accumulation of protein fragments in neurodegenerative
diseases such as AD, PD, and HD alters normal NSC function
and can promote a senescent phenotype (Conforti et al., 2013;
He et al., 2013; Zasso et al., 2018).
Changes in NSC metabolism help balance self-renewal and
differentiation, which includes mechanisms involved in energy
generation (Rafalski and Brunet, 2011; Ochocki and Simon,
2013). A major emphasis has been placed on contextualizing
mitochondrial dysfunction and NSC aging and whether it
supports the mitochondrial theory of aging, which proposes that
chronic mitochondrial dysfunction underlies the great majority
of age-related deficits (López-Otín et al., 2013). This theory is
not without merit, as the capacity of antioxidants to scavenge
ROS in the brain is impaired with age, allowing the extra-
and intracellular accumulation of ROS and subsequent oxidative
stress and damage (Siqueira et al., 2005). Quiescent NSCs are
intrinsically glycolytic unless activated for proliferation wherein
a metabolic switch to mitochondrial respiration via oxidative
phosphorylation (OXPHOS) occurs to meet the new energy
demands of the cell (Coller, 2019). However, aging impairs
mitochondrial respiration through a variety of factors that
damages the machinery necessary for controlled activation of
NSC proliferation and differentiation, directly impacting adult
neurogenesis (Figure 2; Llorens-Bobadilla et al., 2015; Stoll
et al., 2015). For example, conditional deletion of the energy-
producing mitochondrial enzyme complex alpha-ketoglutarate-
dehydrogenase reduces the proliferative potential of NSCs
residing in the SGZ of the hippocampus (Calingasan et al.,
2008). Alterations in other mitochondrial properties, such as
fusion and fission, impair NSC proliferation in the SGZ of the
adult rodent hippocampus leading to deficits in spatial learning
(Khacho et al., 2016). Additionally, stem cells upon division
apportion aged mitochondria, leaving a daughter cell with an
accumulation of aged, fragmentedmitochondria causing a deficit
in stemness properties (Katajisto et al., 2015). Therefore, normal
mitochondrial function is critical in maintaining healthy NSC
niches, allowing NSCs to react appropriately to the changing
energy needs of the brain.
Nutrient sensing by NSCs within niches is inherently linked
to the regulation of their activation state. Recently, mechanisms
through which calorie restriction promotes longevity in NSCs
have been uncovered (Van Cauwenberghe et al., 2016). Calorie
restriction prevents age-related declines in neurogenesis, which
likely occurs via a decrease in pro-inflammatory signaling in
the niche (Apple et al., 2019). The effects of calorie restriction
are partly mediated through the insulin/insulin-like growth
factor (IGF)-1 signaling (IIS) pathway which responds to
changes in glucose and is found to regulate NSC function
(Rafalski and Brunet, 2011; Vitale et al., 2019). Inhibition of
IGF-1 signaling in rodent NSCs inhibits age-related declines
and promotes self-renewal of the NSC niche (Chaker et al.,
2015). Intriguingly, signaling through the IIS pathway results
in the downstream activation of mTOR, a pathway with major
implications in aging (Verburgh, 2015). The mTOR pathway
acts as a nexus in amino acid concentration signaling and is
a critical regulator of cellular metabolism and growth. mTOR
signaling is important in regulating the quiescent vs. an active
proliferative state of adult NSCs (Nieto-González et al., 2019).
For example, inhibition of mTOR complex 1 (mTORC1) induces
a reversible quiescent phenotype, which is corroborated by
in vivo findings that diminished mTOR activity in the aged
NSC niche can be reversed by pharmacological intervention
leading to increased proliferation and neurogenesis (Paliouras
et al., 2012; Romine et al., 2015). However, future studies must
proceed with caution when artificially increasing and decreasing
mTOR activity. The mTOR pathway is hyperactivated in both
pre-clinical rodent models of AD and in AD patients with
associated NSC dysfunction, suggesting that finely-tuned mTOR
activity is needed to maintain niche homeostasis (Perluigi et al.,
2015). In this regard, recent evidence has identified reductions
in mTOR activity via rapamycin supplementation concomitant
with the amelioration of age-dependent spatial memory deficits
and increased lifespan in mice (Majumder et al., 2012). Whether
rapamycin treatment has an indirect or direct role in modulating
the aged NSC niche has yet to be tested.
Physical exercise has a positive effect on cognitive functions
in older adults, also reflected in rodent research (Colcombe et al.,
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2006). It has been suggested that aerobic exercise boots aspects of
brain metabolism, including upregulation in the hippocampus of
enzymes involved in glutamate turnover and glucose catabolism
(Ding et al., 2006; Matura et al., 2017). This results in enhanced
proliferation of NSCs and increases in the number of immature
neurons in middle-aged mice (Wu et al., 2008). Voluntary
running in aged mice increases secretion of growth hormone
stimulating proliferation and neurogenesis in the hippocampal
niche of aged mice (Yang et al., 2015). Moreover, increases in
BDNF and IGF-1 significantly increase after voluntary running,
improving neurogenic potential (Adlard et al., 2005). This data
suggests that exercise aids in the proliferation of NSC niches, and
the eventual production of immature neurons through overall
changes in metabolic components.
Oxygen Sensing
Oxygen sensing is a potent regulator of the aged NSC niche.
Hypoxia-inducible factors (HIFs) are transcription factors that
regulate the cellular response to changes in oxygen levels, of
which HIF1α plays a prominent role in NSCs. Conditional
deletion of HIF1α in NSCs of adult mice resulted in a
loss of NSC proliferation within the SVZ, highlighting its
importance in maintaining the adult NSC niche (Li et al., 2014).
Further, chronic mild hypoxia results in dual yet opposing NSC
functions. Chronic mild hypoxia increases NSC proliferation
in the presence of mitogens such as EGF and bFGF, whereas
chronic mild hypoxia promotes differentiation into neurons
in the absence of these mitogens (Xie and Lowry, 2018).
Hypoxia is known to play a role in multiple neurodegenerative
diseases, including AD, PD, ALS, and HD, where it promotes
inflammation and neuronal damage. However, the extent of
the alterations to the NSC niche is unknown (Jha et al., 2018).
Impaired oxygen sensing is reported in aged rodent brains
suggesting a potential mechanism leading to neurogenic decline
with age (Yeo, 2019).
Extracellular Matrix
It is well-established that the ECM is an important component
of the NSC niche serving as an inert scaffold to anchor cells
and dynamically regulate cell fate (Figure 1; Gattazzo et al.,
2014). NSC adherence to ECM molecules such as laminin
(Ln), fibronectin (Fn), and hyaluronan (HA) is facilitated via
integrin receptors, which initiate cellular responses stimulating
proliferation or differentiation. Concerning advancing age, Su
et al. (2017) demonstrated that increased HA deposition within
the dentate gyrus (DG) directly contributes to age-related
reductions in NSC proliferation and differentiation by
overactivation of the CD44 receptor. Further, increased HA
deposition is observed in aged human brain tissue and in
demyelinated MS plaques, the latter impeding remyelination
(Back et al., 2005; van Horssen et al., 2007; Lepelletier et al.,
2017). Stem cell behavior is also dependent on tissue stiffness,
which is determined by ECM composition and organization.
ECM-derived mechanical signals act through Rho GTPases to
activate cellular pathways to alter NSC lineage commitment.
When NSCs are cultured on stiff matrices neurogenesis is
suppressed whereas blocking Rho GTPase in NSCs rescues
differentiation on stiff matrices (Keung et al., 2011). Follow-up
studies identified that soft hydrogels direct cultured adult
NSCs to differentiate into neurons, whereas harder gels were
biased towards glial cell differentiation (Saha et al., 2008).
Counterintuitively, despite overall brain stiffness increasing with
age in both rodents and humans (Elkin et al., 2010; Takamura
et al., 2020), decreased stiffness in neurodegenerative diseases
is linked to a loss of adult neurogenesis (Klein et al., 2014).
These differences could be due to regional heterogeneity in brain
stiffness, which is observed in post-mortem tissue of AD and
PD patients, highlighting the complexity of ECM regulation and
deposition in the aging and diseased brain (Berg, 2011; Murphy
et al., 2016). Moreover, the presence of glial scar tissue and
brain tumors can drastically change the mechanical properties of
the affected brain region in near an NSC niche and, in turn, the
behavior. Thus, the ECM plays a major role in modulating the
activity of the NSC niche in both aging and disease, although
the extent to which it drives total brain aging, and perhaps
neurodegeneration, remain outstanding lines of research.
Extrinsic Regulators, Immunity, and
Inflammation
Key drivers in the development of an aged phenotype in adult
NSCs involve extrinsic large-scale systemic changes reflected in
circulating fluids, including blood, cerebrospinal fluid (CSF), and
lymph which can affect the NSC niche (Figure 1). The blood,
CSF, and lymph display increases in pro-inflammatorymediators
with both age and neurodegenerative disease exacerbating
ongoing brain-wide inflammation and NSC niche dysfunction
(Pluvinage and Wyss-Coray, 2020). Recent work has uncovered
alterations in the human plasma proteome with age, which
become exacerbated with AD (Lehallier et al., 2019). Further
study in what these proteomic changes biologically confer
is warranted.
Due to the SVZ being uniquely situated above the lateral
ventricles, exposure to blood and CSF factors routinely
occurs. Systemic factors have been identified in aged mice
that promote age-induced dysfunction, such as C-C motif
chemokine 11 (CCL11), a chemokine increased in the blood
of aged mice which directly correlates with a decrease in
neurogenesis. Systemic exposure of young mice to recombinant
CCL11 impaired hippocampal neurogenesis, which is rescued
with a CCL11 blocking antibody. Interestingly, CCL11 is
increased in aged human plasma and CSF (Villeda et al.,
2011). β2-microtubulin (B2M) is another circulating pro-aging
factor identified in old mice as well as humans. It negatively
regulates regenerative functions in the hippocampus, including
NSC proliferation and neurogenesis (Smith et al., 2015).
On the other hand, aged mice with cognitive deficits show
improvement after parabiosis with young mice, highlighting
how circulating systemic factors can directly influence brain
homeostasis (Villeda et al., 2011, 2014). For example, several
circulating factors have been identified in young mice which
provide rejuvenation to aged NSC niches, one being growth
differentiation factor 11 (GDF11), a bone morphogenetic
protein. This protein was found to be present in higher
concentrations in young mouse serum compared to aged mouse
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serum. Also, after heterochronic parabiosis of aged mice to
young mice, GDF11 was found increased in the aged mice.
Administration of a recombinant version of GDF11 to aged
mice reproduces similar beneficial effects, such as increased NSC
proliferation and differentiation, as observed in the parabiosis
studies (Katsimpardi et al., 2014). Further work delving into an
earlier developmental stage found that umbilical cord plasma
from humans contains proteins that improve cognitive function
in aged mice, namely tissue inhibitor of metalloproteinases 2
(TIMP2). TIMP2 is enriched in human cord plasma, young
mouse plasma, and in young mouse hippocampi, and declines
with age. Immunodepletion of TIMP2 from cord plasma before
intravenous administration into aged mice blocked the beneficial
cognitive effects emphasizing the importance of systemic factors
in brain aging (Castellano et al., 2017).
The blood-brain barrier (BBB) is comprised of a
microvasculature unit of brain endothelial cells (BECs),
which are exposed to circulating factors on their luminal side
and brain cells on their abluminal side. BECs in aged mice
express an inflammatory transcriptional profile, including
upregulation of vascular cell adhesion molecule 1 (VCAM1).
Soluble VCAM1 is increased in the plasma of both aged humans
and mice. Plasma collected from aged mice and infused into
young mice induced a significant increase in VCAM1 expression
in the BEC population, which caused microglial activation and
decreased the amount of proliferating NSCs. Genetic deletion of
Vcam1 in BECs during adulthood reduced microglial activation
and increased NSC proliferation (Yousef et al., 2019). Given
that aged BECs display a pro-inflammatory profile, exposure to
circulating pro-inflammatory factors may further amplify this
phenotype through induction of VCAM1 expression as well as
induce intrinsic cellular changes associated with aging.
Aging and neurodegenerative diseases are associated with
impaired integrity of the BBB, which creates a more permissive
environment for the entry of peripheral immune cells into
the brain parenchyma (Erdö et al., 2017). Infiltrating T
cells secreting high levels of IFN-γ have been identified in
aged NSC niches. Here, increased IFN-γ led to impaired
NSC proliferation and maintenance of a quiescent phenotype,
impeding differentiation. Markedly, histological analysis of
post-mortem human brain tissue from elderly individuals
identified a similar pro-inflammatory T cell infiltrate in
the SVZ (Dulken et al., 2019). The aberrant infiltration
of T cells into the SVZ in aged mice is supported by
previous work demonstrating that under chronic inflammatory
conditions, such as in the rodent model of MS, experimental
autoimmune encephalomyelitis (EAE), an autoreactive T-
cell-mediated disease model, T cell activation is associated
with a dysfunction in the proliferation and migration of
NSCs due to persistent inflammation (Pluchino et al., 2008;
Rasmussen et al., 2011).
The term inflammaging is used to describe major changes in
aging associated with the accumulation of soluble inflammatory
factors, tissue damage burden, and activation of immune cells
(López-Otín et al., 2013). Overall, the above work supports the
concept that pro-inflammatory molecules from circulating fluids
as well as infiltrating cells affect the NSC niche (Figure 1).
Progenitor cells in the brain also have the capability of secreting
pro-inflammatory factors. One example being senescent stem
cells in progressive MS brains secreting high mobility group
box 1 (HMGB1), a known SASP factor and inflammatory
molecule, which inhibits the differentiation of oligodendrocyte
progenitor cells (OPCs) in vitro (Davalos et al., 2013; Nicaise
et al., 2019). HMGB1 has previously been found to be elevated
in the hippocampus and CSF of aged rats where it promotes
microglial inflammation by stimulating toll-like receptors (TLR)-
2 and -4 (Fonken et al., 2016). Inflammatory factors can also be
secreted by brain cells within the niche microenvironment. A
recent article highlighted the impact of age-associated changes
within the niche, including the activation of microglia, the
resident brain macrophage population (Solano Fonseca et al.,
2016). Increased clusters of activated microglia and peripheral
infiltrating monocytes expressing increased levels of tumor
necrosis factor-α (TNF-α), interleukin-1 β (IL-1β), and IL-6
were identified in the aged SVZ while increased levels of
TGF-β1 were found to be released from SVZ endothelial cells
(Pineda et al., 2013). In vitro modeling demonstrated that
resting, non-activated microglia promote NSC proliferation
and differentiation into neuronal lineages, whereas activated
pro-inflammatory microglia suppressed differentiation (Solano
Fonseca et al., 2016). The pro-inflammatory cytokine IL-1β,
which is released by activated microglia and astrocytes, increases
VCAM1 expression in NSCs repressing them in a quiescent
state, inhibiting neurogenesis, and diminishing expansion of the
NSC pool through self-renewal (Kokovay et al., 2012). Microglia
are not the only contributors to inflammaging. Astrocytes
become reactive with advancing age wherein they secrete
pro-inflammatory molecules (e.g., IFNs) directly impacting local
cell networks (Clarke et al., 2018). Corroborating data from
animals lacking global expression of IFN receptors demonstrate
an absence of age-related declines in NSC activation; rather,
NSCs readily activate from quiescence as observed in young
animals (Kalamakis et al., 2019). Unsurprisingly, an increased
response to IFN is detected in the aged human brain which
is thought to negatively affect brain functions (Baruch et al.,
2014). Overall, these data suggest that chronic inflammation in
the brain, whether a result of age, on-going neurodegenerative
disease activity, or a combination of both, maintains NSCs in
a quiescent state, repressing their capacity to proliferate and
differentiate (Figure 2).
These findings demonstrate that both systemic and
local factors are altered with age and disease, as well as
widespread accumulation of senescent cells, leading to profound
impacts on NSCs and niche microenvironment. However,
it remains to be understood how alterations in the absolute
amounts of these factors in advancing age and age-related
neurodegenerative diseases lead to enhanced or diminished
endogenous NSC function.
Importantly, intrinsic and extrinsic changes associated
with aging do not occur in isolation, rather they interact
synergistically. For example, changes in diet are reflected in
fluctuations of physiologic factors in the CSF, such as IGF-1
and insulin, which in turn contributes to intrinsic epigenetic
regulation of NSCs (Mihaylova et al., 2014; Mir et al., 2017).
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Further, cell-intrinsic aging, which is reflected in senescent
NSCs, alters the extrinsic microenvironment via the activity of
the SASP.
SASP then leads to an amplification of local cellular
dysfunction as SASP factors spread to and impair the
normal functioning of local cells which in turn leads to
further cell-intrinsic changes and beginning the cycle anew
(Coppé et al., 2010).
Therefore, NSC aging cannot be attributed to a single
factor, rather it involves a complex interplay of both intrinsic,
including DNA damage, and extrinsic factors, such as secretion
of inflammatory factors, which all contribute to dysfunction
alterations in the stem cell niche.
MODELING BRAIN AGING IN VIVO
Studying brain aging in vivo is a challenging endeavor given that
the regulation of age is heterogenous amongst different tissues
and species (Zahn et al., 2007), however, research has primarily
focused on evolutionarily conserved mechanisms that control
aging to better facilitate data extrapolation to humans. Numerous
mouse models of aging have been established and extensively
reviewed (Yeoman et al., 2012; Heng et al., 2017; Folgueras et al.,
2018). Nevertheless, the field is still in its infancy, and major gaps
in our knowledge exist regarding how the aging process impacts
the central nervous system (CNS), specifically NSC function and
maintenance. Here, we are going to briefly cover findings from
mouse models of accelerated aging in which an NSC phenotype
has been described.
Mouse models recapitulating aspects of genomic instability
associated with aging have been established and extensively
used to study this biological process in non-CNS tissue as
reviewed elsewhere (Specks et al., 2015; Folgueras et al., 2018).
Many mouse models of aging have been generated based on
genetic correlates of progeroid human syndromes. Progeroid
syndromes are a group of genetic disorders that make individuals
biologically older than they are, typically due to a monogenic
mutation in DNA repair mechanisms or lamin (Gordon et al.,
2014). However, there are some mouse models based on
progeroid syndromes that do not exhibit an NSC dysfunction,
one example being a mouse model Hutchinson-Gilford progeria
syndrome (HGPS). HGPS is caused due to a mutation in the
lamin A gene, resulting in the build-up of the truncated form
of lamin A, called progerin. Despite lamin A being ubiquitously
expressed by various cell types, induced mutation of LMNA
in the brain of mice did not affect behavior or neurogenesis
assays of hippocampal cells, suggesting a protective mechanism
(Baek et al., 2015). However, there are other relevant mouse
models of aging that possess an NSC phenotype which will be
further discussed.
Benzimidazole-Related 1 (BubR1) Mutants
BubR1 is a spindle assembly checkpoint kinase, encoded by
Bub1b, that is critical for the accurate separation of duplicated
chromosomes during cell division and maintaining genomic
stability (Wassmann and Benezra, 2001; Cleveland et al., 2003).
Reduced BubR1 expression induces aneuploidy, which affects
genomic stability (Baker et al., 2004). Further, deficiencies in
DNA repair pathways cause progeria syndromes in humans
which display CNS pathologies (Gordon et al., 2014). Natural
aging significantly reduces BubR1 expression within the DG of
the hippocampus in an age-dependent manner, with the largest
reductions observed at 24 months of age. Interestingly, it only
takes 2 months for BubR1 insufficient mice (BubR1H/H) to reach
a similar expression level to that of wild-type mice at 24 months
of age. NSC proliferation and maturation were significantly
reduced in BubR1H/H mice impairing hippocampal neurogenesis
despite having no impact on neuronal survival (Figure 2;
Yang et al., 2017). An independent study identified a similar
impairment in NSC proliferation following lentiviral knockdown
of BubR1 in wild-type adult mice, confirming the strength of the
BubR1H/H mouse model in recapitulating aspects of NSC aging.
Further, a follow-up study using the BubR1H/H mice found that
inhibition of the endogenous Wnt antagonist, secreted frizzled-
related protein 3 (sFRP3), rescued NSC proliferation in the
hippocampal DG in these mice (Cho et al., 2019).
These data highlight how mouse models of genomic stability
can be employed to not only rapidly and faithfully recapitulate
specific hallmarks of aging in vivo but allow for a mechanistic
understanding of the aged NSC phenotype.
Telomerase Mutants
Telomerase-deficient mice have served as a model system
to study the adverse cellular and organismal consequences
of wide-spread endogenous DNA damage signaling activation
in vivo. In these mice, telomere loss and uncapping provoke
progressive tissue atrophy, stem-cell depletion, and impaired
tissue injury responses (Sahin and Depinho, 2010). Telomere
attrition in NSCs is of particular interest as loss of proliferative
potential and stem cell exhaustion with age is thought to be
correlated with the age-related cognitive decline observed in
mice and humans (Ferrón et al., 2009). Currently, there are two
established telomere attrition mouse models with an associated
NSC phenotype.
In one mouse model, mice carrying a homozygous germline
deletion for the telomerase RNA component gene (Terc−/−)
showed a complete loss ofTerc expression and telomerase activity
(Blasco et al., 1997). Inducing telomere shortening in these
mice requires successive generations (>3 generations) of mating
to establish phenotypic changes (Blasco et al., 1997). Third
generation Terc−/− mice show reduced neurogenesis in the SVZ
of the DG and loss of neurons in the hippocampus and frontal
cortex, suggestive of an impairment in the proliferation and
maturation capacity of NSCs (Ferrón et al., 2004; Rolyan et al.,
2011; Khan et al., 2015).
In the other mouse model, deficiency in telomerase
reverse transcriptase (Tert−/−), a catalytic subunit of the
telomerase complex, induces aging phenotypes similar to that
observed in Terc−/− mice, such as impaired spatial memory,
dendritic development, and neurogenesis (Strong et al., 2011;
Zhou et al., 2017).
Interestingly, in a tamoxifen-inducible Tert−/− mouse model
(TERT-ER) somatic telomerase reactivation reversed these
observed deficits through the restoration of proliferating Sox2+
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NSCs and new-born neurons, consistent with the integral role of
SVZNSCs in the generation andmaintenance of mature neurons
in adulthood (Jaskelioff et al., 2011).
Thus, these transgenic mice provide excellent models for
the study of the deficits in proliferation observed in NSCs of
aged animals.
Mitochondrial DNA Mutants
It is well accepted that mitochondria play a central role in
the maintenance of NSCs in development and throughout
adulthood, with oxidative phosphorylation an essential regulator
of NSC proliferation and differentiation (Cabello-Rivera et al.,
2019; Khacho et al., 2019). Consequently, age-associated
alterations in mitochondrial function are thought to have a
profound effect on the ability of NSCs to self-renew (Khacho
et al., 2019). Mutations in the mitochondrial genome increase
with age (Vermulst et al., 2007) and are associated with an
increase in the production of mitochondrial ROS, which are
potent signaling molecules that can impair stem cell self-renewal
capacity (Hämäläinen et al., 2015).
Mouse models of advanced aging accumulate mtDNA
mutations (PolgA and Tfam), associated with reductions
in quiescent NSCs and a loss of self-renewal in the adult
SVZ (Ahlqvist et al., 2012; Beckervordersandforth et al.,
2017b). Further, NSC-specific ablation of nicotinamide
phosphoribosyltransferase (Nampt), a rate-limiting enzyme
that salvages the essential metabolic cofactor nicotinamide
adenine dinucleotide (NAD+) and the main source of NSC
NAD+ required for cell-cycle progression, reduced the NSC
pool and their proliferation in adult mice (Stein and Imai,
2014). Importantly, these phenotypes can be rescued via
supplementation of N-acetyl-L-cysteine and nicotinamide
mononucleotide in the PolgA and Nampt mouse models,
respectively (Ahlqvist et al., 2012; Stein and Imai, 2014).
Therefore, mouse models of accelerated aging as a result of
mitochondrial dysfunction can serve not only a basic research
role but also in the development of therapies aimed at reversing
these aging phenotypes.
SAMP8 Mice
A non-transgenic mouse model of accelerated aging exists.
SAMP8 mice are a specific strain of inbred mice that exhibit a
senescence-accelerated phenotype, which could be used to study
how intrinsic homeostatic mechanisms of NSCs change with
age. This short-lived strain progressively develops learning and
memory deficits, along with a multisystemic aging phenotype
(Takeda, 2009). The mice develop increased oxidative stress and
astrogliosis in the brain, along with an accelerated loss of the NSC
pool associated with a rise in astrocyte differentiation (Figure 2;
Soriano-Cantón et al., 2015).
Consideration must be taken when interpreting results from
these mice as extensive astro- and microgliosis is observed
in parallel with the deficits in NSCs (Soriano-Cantón et al.,
2015). No current studies have investigated the potential impact
activated astrocytes and microglia in the (accelerated) aging
hippocampus have on resident NSCs. Therefore, these mouse
models provide a valuable tool to not only study cell-specific
effects of aging but also in untangling the cell-cell interactions
of NSCs and resident (or peripheral) cells in the context of aging.
MODELING BRAIN AGING IN A DISH WITH
STEM CELL TECHNOLOGIES
To model human brain diseases in a dish, many laboratories
rely on induced pluripotent stem cells (iPSCs) rather than
somatic aged brain cells, which are rare and difficult to
obtain. Additionally, human post-mortem samples reflect cell
states at the end stage of the disease, hindering the study of
disease pathogenesis. To generate iPSCs, primary human cells,
such as fibroblasts or blood cells, are reprogrammed to an
embryonic-like state, similar to embryonic stem cells (ESCs),
through the expression of Yamanaka transcription factors. iPSCs
are then given cues to direct differentiation towards the mature
cell of interest to model disease. Typically, iPSCs are used
to model diseases with genetic origins, such as ALS (SOD1
mutation), familial PD (mutations in Parkin and PINK1), and
HD (HTT mutation), yet many sporadic forms of these and
other diseases occur with increasing age, such as sporadic PD,
ALS, and progressive MS (PMS; Niccoli and Partridge, 2012;
Reeve et al., 2014). iPSCs generated with specific mutations and
deletions reflective of the disease state are an invaluable tool
for understanding how familial genetic alterations change cell
phenotype. However, the consideration of aging signatures is
rarely considered.
Mimicking age-related defects in cells has proven difficult as
reprogramming acts as a developmental reset, removing some of
the known aging markers that were evident in the somatic cell
of origin (Studer et al., 2015). These markers include epigenetic
patterns, DNA damage, mitochondrial dysfunction, telomere
length, and senescence, which are diminished or absent either
during iPSC induction and/or further differentiation into the cell
of interest (López-Otín et al., 2013).
The following reprogramming into iPSCs, several
age-associated markers (including genetic and proteomic
signatures) were reset, and cells retained a youthful phenotype
(Miller et al., 2013). Despite this evidence, it is still unclear to
what extent markers of the cell of origin are retained as it has also
been shown that reprogrammed iPSCs can exhibit differentiation
biases when further differentiated into a cell type of interest.
This is of particular importance not only for cells in disease
models but identifying what constitutes an aging signature vs. a
disease-related signature. For example, NSCs differentiated from
iPSCs reprogrammed from primary progressive MS (PPMS)
patient fibroblasts and primary blood mononuclear cells exhibit
a senescence phenotype compared to age-matched healthy
patients (Nicaise et al., 2019). PPMS NSCs secrete SASP factors
in vitro and inhibit remyelination in an in vivo model of PPMS,
which was attributed to a dysfunctional phenotype arising from
intrinsic defects in NSC function (Nicaise et al., 2017). Whether
the NSCs retained an epigenetic or genetic signature unique
to PPMS disease during iPSC reprogramming is unknown
(Nicaise et al., 2019). This may also indicate that labile disease-
associated markers which are lost with reprogramming are not
necessary to recapitulate salient features of the disease or aging
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in the reprogrammed cells, therein pointing to the unmodified
processes as playing a more important role in the preservation of
‘‘age’’ or disease underlying the utility of these cellular models.
In support of these findings, a higher frequency of age-related
mtDNA mutations is identifiable in iPSCs reprogrammed from
fibroblasts of aged individuals compared to reprogrammed
fibroblasts from young individuals. This work demonstrates that
cellular reprogramming does not completely remove epigenetic
markers nor the propensity of aged cells to accumulate mutations
(Kang et al., 2016). Nor does iPSC reprogramming abrogate
the potential for the study of idiopathic forms of the disease,
as iPSC-derived astrocytes from non-genetic forms of ALS
recapitulate the disease-related phenotypes of genetically
confirmed ALS iPSC-astrocytes (Haidet-Phillips et al., 2011).
Overall, these studies raise further questions regarding the
conservation of age-related changes under disease conditions or
whether disease conditions exacerbate the expression of markers
of cellular aging (Table 1).
There is no universally agreed upon and established metric
for determining cellular age, however, DNAmethylation patterns
are observed to correlate with chronological age, termed
‘‘epigenetic age.’’ One model which uses DNA methylation
patterns is named Horvath’s model and is based on 353 CpG
methylation sites in cells and tissues that allow for the
quantifiable measurement of cellular biological age as well as an
estimation of age acceleration (i.e., contrasting DNAmethylation
age with chronological age; Horvath et al., 2012). The specific
methylation sites correlate to 0 years of age in ESCs, are reflected
in somatic cells as the age of the donor but become largely erased
upon iPSC reprogramming (Horvath et al., 2012; Horvath, 2013;
Sheng et al., 2018).
Instead, direct induction of somatic cells to induced NSCs
(iNSCs), retains 5–30% of the original aged methylation pattern
according to the Horvath model, making them an ideal candidate
to study aging both in the context of health and disease (Sheng
et al., 2018). Direct induction of cells bypasses the pluripotency
step, wherein somatic cells are forced to express the Yamanaka
factors transiently then cued to become NSCs using growth
factors in vitro (Thier et al., 2012). Recent work profiled markers
of aging in young and aged blood cells, as well as iPS-NSCs
and iNSCs from the same patients, and somatic fetal NSCs.
Blood cells from aged patients match the estimated age based on
Horvath’s model and possess shortened telomeres and an aged
transcriptome, which was absent in the iPS-NSCs. Rather, iNSCs
retain specific methylation patterns observed in the blood cells
and shortened telomere length, while iPS-NSCs closely match
the somatic fetal-derived NSCs (Sheng et al., 2018; Table 1).
Whether these DNA methylation patterns are reflective of aging
within cells or causative transcriptomic changes inducing cellular
dysfunction is unknown.
The forced expression of neurogenic transcription factors in
fibroblasts results in the generation of directly induced neurons
(iNs), which are further differentiated in vitro to obtain a more
mature neuronal subtype (Vierbuchen et al., 2010).
Induced motor neurons (iMNs) from primary fibroblasts
or iPS-NSCs retain many of the aging hallmarks of the
old donors, including increased DNA damage foci (γH2AX),
SA-β-galactosidase activity, and loss of heterochromatin and
nuclear organization (Tang et al., 2017). Aging signatures in
iMNs derived from iPS-NSCs were largely erased. Further work
using both iPSC-derived neurons and iNs from aged patients
identified that decreased Ran-binding protein 17 (RanBP17)
in aged iNs is responsible for the age-dependent loss of
nucleocytoplasmic organization, which is reset in iPSCs (Mertens
et al., 2015). Also, mitochondrial dysfunction present in the
somatic cell is exacerbated in aged iNs, supporting the theory of
metabolic dysfunction driving brain aging (Hoffman et al., 2017;
Kim et al., 2018; Table 1).
The culmination of this work highlights the power of direct
induction in disease modeling to further our understanding of
the processes underlying age-related deficits in cells (Liu et al.,
2016; Nekrasov et al., 2016). Unfortunately, caveats remain with
this technology, such as the glaring fact that neurons are post-
mitotic, restricting their use in large-scale applications, such as
drug screens, due to the lack of a proliferative intermediate cell.
However, their value lies with the insight into understanding
neuronal aging in the context of health and disease. In the future
it will be important to explore how disease-associated and aging
phenotypes can be retained in iNSCs, and if direct induction into
other brain cell types, such as astrocytes and oligodendrocytes,
will uncover unknown roles of these cells in aging and disease.
Despite iPSCs losing some markers of aging during the
reprogramming process, they are a valuable tool that can
generate, theoretically, endless amounts of specialized cells
for researchers to investigate. Some genetic mutations have
been found to accelerate aging, including point mutations
within the lamin A (LMNA) gene, which was identified in
HGPS. Modification of the LMNA transcript results in a
truncated form of lamin A called progerin. Progerin acts to
shorten telomeres, inflict DNA damage, and encourage cellular
senescence. Interestingly, iPSCs from patients with HGPS do
not show an accumulation of progerin and lack the cellular
alterations associated with accelerated aging, however, this
phenotype is reinstated following iPSC differentiation into
smooth muscle cells (Liu et al., 2011). This system was applied
to iPSC-derived neurons from PD patients to determine the
effect of aging on this disease. The researchers transfected
progerin into iPSC-derived dopaminergic (DA) neurons from
both healthy and genetic PD subjects and discovered disease-
specific phenotypes. Progerin transfected PD cells developed an
aging phenotype displayed by the progressive loss of tyrosine
hydroxylase (TH) expression, enlarged mitochondria, and Lewy-
body-precursor inclusions compared to healthy cells transfected
with progerin, despite these cells still displaying accelerated
aging signatures such as DNA damage foci (Miller et al., 2013).
This work indicates that forced progerin expression can induce
age-associated marker expression, but it is unknown if this
method faithfully recapitulates cellular phenotypes observed in
advancing age and disease.
Hydroxyurea (HU), used for the treatment of leukemia,
disrupts cellular proliferation, and has been found to induce
senescence in human cells (Park et al., 2000). Treatment of
rodent NSCs in vitro with (HU) robustly induces cellular
senescence identified by increased p53 and p16Ink4a expression,
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TABLE 1 | List of studies using human stem cells to study cellular brain aging and disease.
Cell type Donor ages
(years)
Disease Phenotypes and markers Reference
iPSCs 24–72 None Increased frequency of mitochondrial DNA mutations
with age.
Kang et al. (2016)
iPS-NSCs 45–66 PPMS Displayed senescence markers, secreted pro-inflammatory
factors inhibiting OPC differentiation.
Nicaise et al. (2019)
hES-NSCs treated with
hydroxyurea
Embryonic None Exhibited cellular senescence, impaired mitochondrial
metabolism.
Daniele et al. (2016)
iNSCs 30–60 None Cells retained 5–30% of donor cells epigenetic aging
markers.
Sheng et al. (2018)
iPS-neurons with progerin
overexpression
11–96 PD and HGPS Dendrite degeneration, loss of TH, increased DNA damage
and mitochondrial ROS.
Miller et al. (2013)
iPS-neurons treated with
telomerase inhibitor
N/A PD Increased DNA damage, reduction in dendrites, increased
mitochondrial ROS.
Vera et al. (2016)
iNs 0–89 None Transcriptomic aging, loss of nucleocytoplasmic
organization.
Mertens et al. (2015)
iNs 6–71 HD HD gene expression increased DNA damage and ROS
production, protein aggregates.
Victor et al. (2018)
iNs 0–89 none Mitochondrial dysfunction—impaired energy production,
lower mitochondrial membrane potential.
Kim et al. (2018)
iNs 37–71 ALS Soma shrinkage, hypoactivity. Liu et al. (2016)
Abbreviations: ALS, amyotrophic lateral sclerosis; HD, Huntington’s disease; hES, human embryonic; HGPS, Hutchinson-Gilford progeria syndrome; iNs, induced neurons; iNSCs,
induced neural stem cells; iPS, induced pluripotent stem; NSC, neural stem cell; OPC, oligodendrocyte progenitor cell; PD, Parkinson’s disease; PPMS, primary progressive multiple
sclerosis; ROS, reactive oxygen species; TH, tyrosine hydroxylase.
SA-β-galactosidase staining, and downregulation of DNA repair
proteins, which has also been replicated in human NSCs in vitro
(Daniele et al., 2016). This model led to the formation of
aging hallmarks through DNA damage, similar to ROS-induced
damage in the brain, yet it is unknown if it faithfully recapitulates
every aspect of aging, including telomere shortening andHorvath
DNA methylation patterns (Dong et al., 2014; Table 1). HU
treatment of NSCs derived from disease models, either directly
induced or from iPSCs, has yet to be investigated but may yield
interesting results.
Ionizing irradiation, which causes severe DNA damage and
inhibits the proliferation of NSCs, is used to study senescence
in vitro, however, it is unknown how well this faithfully
recapitulates cellular hallmarks of aging (Schneider, 2014).
The aforementioned studies, which are summarized in
Table 1, describe models that recapitulate some, but not all,
of the key characteristics of cellular aging. However, each
model comes with its own set of limitations. Thus far, iNs
retain the largest number of aging markers identified within
the parent cell, including maintenance of DNA methylation
age, transcription of aging-associated factors, and mitochondrial
dysfunction. Unfortunately, iNs do not capture the entire gestalt
of the aging brain, nor do they have a proliferative intermediate
to derive other cell types, but they are ideal for studying neurons
in the context of diseases of aging. Their use in modeling
aging and age-related disease is reviewed in depth elsewhere
(Mertens et al., 2018). iNSCs may prove more useful for further
interrogation of aging in disease as iNSCs are known to retain
5–30% of age-related DNA methylation markers from the cell
of origin and have the capability to differentiate into astrocytes,
oligodendrocytes, andmicroglia when prompted. iPS-NSCs from
patients with PPMS have shown a senescent phenotype, however,
iNSCs have yet to be used to model any age-associated disease.
Forced expression of verified aging-associated proteins and
treatment with inducers of senescence are viable alternatives
in creating cellular aging hallmarks. Therefore, induced cellular
aging may serve as a method to study how certain proteins
or extrinsic factors affect pathways related to cellular aging
in specific cell types, but their faithfulness in capturing the
natural aging and disease process is debated. Since aging is
a multifactorial process, applying a multipronged approach
(i.e., disease based iNSCs or iPS-NSCs treated with cellular
stressors) will help further elucidate new pathways and enhance
our understanding of aging and disease. As such, these models
may be especially useful in the sporadic forms of diseases, such as
MS, PD, AD, and ALS, where no obvious genetic causes exist, or
affect more than one cell type in the brain and involve aging.
NOVEL THERAPEUTICS FOR BRAIN
AGING
With the emerging picture of experimental and pathological
data pointing to disease-associated aging among progenitor cell
populations, how might this be targeted for therapeutic benefit?
Certainly, approaches such as caloric restriction and lifestyle
can influence the risk of disease, but for some conditions, a
patient’s ability or compliance for these approaches would also
represent a challenge. Hence, pharmacological approaches to
affect the aged cells within tissues are being actively explored
as viable strategies to limit disease progression and/or stimulate
endogenous regeneration and recovery (Table 2).
Drug screens using NSCs are not as common as disease-
specific cell types such as oligodendrocytes for MS or neurons
in diseases such as AD and PD. However, when considering
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TABLE 2 | List of novel therapeutics for brain aging.
Class Definition Drugs/Agents available Mechanism of action Citations using therapeutics
on CNS cells
Senomorphics Compounds that actively
alter the physiology of
senescent cells.
Metformin, rapamycin Metformin—acts on Akt to
inhibit mTOR
Rapamycin—inhibits mTOR
Neumann et al. (2019) and
Nicaise et al. (2019)
Senolytics Compounds that actively
kill senescent cells.
A combination of dasatinib
(D) and quercetin (Q), fisetin




Currais et al. (2018) and
Zhang et al. (2019)





Park et al. (2013) and
Zhang et al. (2017)
Abbreviations: CNS, central nervous system; mTOR, mammalian target of rapamycin.
the potentially influential role of senescent NSCs in the context
of impaired regeneration or functionality, the paucity of high
throughput or high content screens using rodent NSCs, or
disease-specific NSCs, represents a potential opportunity for
therapeutic interventions for a range of neurological conditions.
Conceptually, the effect of NSCs as a source of disease-related
impairment would mean that drug screens using NSCs would
not only impart effects for neurogenesis but potentially also
a means to address microgliosis, astrogliosis, and promote
myelin regeneration (Kim and Jin, 2012). In terms of the latter,
targeting cellular senescence in NSCs could represent a means
by which to affect cognitive decline which is linked to reduced
myelination with advancing age (Wang F. et al., 2020). Similarly,
the diminished neuroendocrine function of the hypothalamus is
associated with the cognitive decline with advancing age and a
consequence of loss of hypothalamic NSC functions (Zhang et al.,
2013). This loss of function is a result of the NSC senescence of
hypothalamic NSCs (Xiao et al., 2020).
Using primary neurospheres of murine hypothalamic NSCs,
the long non-coding RNA Gm31629 was found to be reduced
with aging and function as a biomarker of cellular senescence
through a stabilized interaction with Y-box1 (YB-1) protein
(Xiao et al., 2020). Based on this, nuclear magnetic resonance
(NMR) was applied to understand how Gm31629 conferred
stability to YB-1 to then perform a molecular docking and
virtual screen of a library of natural small molecule compounds
that identified theaflavin 3-gallate (TF2A; Xiao et al., 2020).
This compound, a theaflavin found in black tea, was found
to reverse senescence-like changes in senescent cells, and
administration to 12-month-old mice reduced the rate of
age-related decline (Xiao et al., 2020). These findings prompt
several conclusions: (i) NSCs are an important site of cellular
senescence; (ii) NSCs can exert widespread functions in aged
animals throughout the body; and (iii) NSCs can be effectively
used to screen and identify anti-senescence agents. From these
data, future screens employing human disease-specific NSCs
would be warranted to address the role of cellular senescence
in this population plays in contributing to neuropathology and
disease progression.
Further screens of existing chemical libraries have yielded
nomenclature to describe two categories of senotherapeutic
agents, termed ‘‘senomorphics’’ and ‘‘senolytics’’ (Table 2).
Senomorphics
Senomorphic agents are compounds that actively alter the
physiology of aged cells, thereby mitigating their influence
on the cellular environments in which they reside (Table 2;
Tchkonia et al., 2013). Specifically, these compounds disrupt
or block the production and release of pro-inflammatory
factors that comprise the SASP (Farr and Khosla, 2019).
Senomorphics thereby block the paracrine effects of senescent
cells on other cells, limiting the impact of the SASP on
impaired tissue function and/or regenerative potential. Examples
of senomorphic agents which have been explored in the context
of aging in demyelinating disease include metformin and
rapamycin. Of particular relevance to our discussion on NSCs
is the recent report demonstrating the utility of metformin to
enhance the myelinating capacity of OPCs in the aged CNS
(Neumann et al., 2019). Rapamycin is a naturally occurring
macrolide product first isolated in 1931 from a bacterium found
in the soil on Easter Island (Rapa Nui) in the south Pacific
Ocean (Vézina et al., 1975). The anti-inflammatory actions of
rapamycin are mediated by the kinase mTORC1 (Brown et al.,
1994). Similarly, metformin acts via Akt (PKB) to inhibit mTOR
signaling (Dowling et al., 2007). Interestingly, a CRISPR-Cas9
knockout gene screen of senescent cells identified MTOR as a
critical checkpoint required for the SASP (Liu et al., 2019), in
part, via attenuated nuclear factor kappa-light-chain-enhancer of
activated B cells (NFkB) signaling and suppressed IL-1RA levels
(Laberge et al., 2015; Liu et al., 2019). Consistent with these
findings, we had recently determined that NSCs derived from
MS patient iPSC lines exhibit a cellular senescence phenotype
and upregulated mTOR expression. Treatment of these patient
NSCs with rapamycin was similarly found to both reduce mTOR
expression and the senescent phenotype in this cellular model
(Nicaise et al., 2019).
Senolytics
Senolytic agents represent the second class of agents to
therapeutically address the impact of cellular aging in intractable
or incurable diseases. The compound term senolytic refers to
the mechanism of action of this class which is to selectively
kill cells that are senescent to reduce the impact of these cells
on tissues (Table 2). This novel class of agents was named
by Zhu et al. (2015). Using irradiated fat cells, they validated
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six anti-apoptotic targets by siRNA, which included B-cell
lymphoma-extra large (BCL-XL) and ephrin type-B receptor 1
(EPHB1), that were found to promote senescent cell death but
did not affect the viability or proliferation of non-senescent
cells. From this, a limited biased screen of select compounds
identified the combination of dasatinib (D), an SRC-family
protein-tyrosine kinase inhibitor approved for the treatment of
leukemia, and quercetin (Q), a dietary flavonoid with estrogen
mimetic activity and pleotropic kinase inhibitor (Russo et al.,
2014), were found to be most effective in clearing/killing
senescent cells (Zhu et al., 2015). Other agents in the senolytic
class, such as fisetin (Zhu et al., 2017), which mimics the
effects of dietary restriction, are also in development for their
potential to target senescent cells in disease models including
CNS conditions (Currais et al., 2014, 2018). Characterization of
the impact of these agents on the CNS requires more extensive
study, as it is unknown to what extent killing senescent cells
would alter the brainmicroenvironment. A potentially important
caveat to the application of these agents to CNS disease is
that in many instances the molecular basis for understanding
cellular senescence is from irradiated (10 Gy) non-neural
primary cells such as fibroblasts or fat cells. Although these
studies and screens provide an important molecular template for
identifying cellular senescence in other tissues, including CNS,
the precise translation of changes evoked by irradiation to disease
conditions within the CNS may be incomplete and likely there
exist important differences requiring further characterization
and study.
Experimental evidence from transgenic animal models has
shown the potential utility of senolysis as an effective strategy to
target senescent cells in the CNS in vivo. Currently, experimental
models of AD are being tested as prototypic neurological diseases
of aging (Mendelsohn and Larrick, 2018). For example, Baker
et al. (2011) developed a transgenic mouse in which senescent
p16Ink4a+ cells are killed by the initiation of apoptosis through
chemically included expression of ATTAC, a caspase inducer
sequence. They recently reported that astrocytes and microglia
develop an aged, p16Ink4a+ (senescent) phenotype in a presenilin
mouse model of AD-related tauopathy (MAPTP301SPS19;
Yoshiyama et al., 2007). Then, using the INK-ATTAC transgenic
mice, they demonstrated that selective elimination of these
p16Ink4a+ cells improves the phenotype and amyloid load in
a MAPTP301SPS19 mouse model of tau-dependent AD-like
disease (Bussian et al., 2018). Importantly, this study used
electron microscopy to show that neurons do not develop a
senescent-like phenotype. This was indicative that cells with
proliferative potential may be key players in neurological illnesses
associated with aging (Bussian et al., 2018), whereby microglia
play an important role in shaping neuropathology. Consistent
with this transgenic study, the identification of senescent-like
changes in p21+ and p16Ink4a+ OPCs is associated with amyloid
plaques in human AD autopsy neurospecimens and in an
APP/PS1 mouse model of AD (Zhang et al., 2019). They also
demonstrated that the use of the senolytic combination D
+ Q effectively eliminates the abundance of senescent cells,
which was coincident with a dramatic improvement of cognitive
performance and lowered amyloid load in treated APP/PS1 mice
(Zhang et al., 2019). Similarly, the senolytic fisetin has been
reported to ameliorate cognitive deficits in APPswe/PS1dE9 AD
mice (Currais et al., 2014). Hence, accumulating evidence
supports a role for cellular senescence associated with cognition
and neuroinflammation in AD. The impact of these agents
on cognitive decline in aged individuals without associated
neurological diagnosis or other neurodegenerative diseases will
require further study.
Cell Transplantation
NSCs have shown promising effects as exogenous stem cell
therapeutics in the treatment of many mouse models of
neurodegenerative diseases, such as PD, AD, MS, and ALS
(Martino and Pluchino, 2006; Pluchino et al., 2009; Willis
et al., 2020). Major strides have been made in harnessing their
restorative, regenerative, and protective potential in the hopes of
treating these devasting diseases. NSC transplants not only act
as a cell replacement strategy but also secrete factors that can
promote endogenous regeneration (Table 2). However, if their
usefulness becomes diminished in an aged milieu is unknown.
An important caveat in cell transplantation is the idea of
host-to-graft transfer of disease, which has been observed in
PD patients. Foetal-derived NSCs transplanted into patients
were found to last up to 16 years but eventually developed
alpha-synuclein-positive Lewy bodies (Li et al., 2008). This
work stresses the importance of the extracellular milieu and
how it can affect even NSCs of fetal origin. As described in
the above section, there is a myriad of extrinsic aging factors
that would affect the transplanted graft. For example, the
increase in pro-inflammatory factors, as well as the build-up
of dysregulated proteins may outweigh the benefit of the
transplanted cells and affect the overall success, possibly even
turning transplanted cells senescent. Early work points to
the success of fetal NSC transplants into aged rats, resulting
in cognitive improvements. However, cells transplanted into
aged and damaged environments demonstrate lower graft
survival (Winkler, 2001; Zaman and Shetty, 2002). Interestingly,
combining neurotrophic supplementation of brain-derived
neurotrophic factor (BDNF) and neurotrophin-3 (NT-3),
along with a caspase inhibitor, allows the graft to survive.
Genetically engineeredNSCs, which are resilient to inflammation
(expressing dominant-negative nuclear factor of kappa light
polypeptide gene enhancer in B-cells inhibitor, alpha [IκBα]),
display an improvement in survival after transplantation into
aged mice (Zhang et al., 2017). Not only can cells be engineered
to be more resistant to hostile conditions, but they can also
be genetically altered to secrete increased growth factors and
even enzymes, such as choline acetyltransferase (ChAT), which
is found to improve cognitive function in aging animals (Park
et al., 2013). These examples suggest the idea of a multifaceted
approach where young NSCs can be harnessed to secrete
pro-rejuvenating and neurotrophic factors, such as TIMP-2,
to help promote endogenous niche activation and eventually
brain regeneration in aging and disease (Castellano et al., 2017).
This method could potentially be used in conjunction with
a senomorphic approach to have the most effect. However,
as noted above, to what extent young NSCs or genetically
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modified NSCs remain healthy and unperturbed by the aged
environment is unknown. Over time the chronically inflamed
brain may confer age-related changes onto the transplanted
cells rendering them as dysfunctional as the endogenous niche.
Stem cell therapy for neurodegenerative disease and aging
may hold the promise of regeneration, nevertheless, many
hurdles remain.
CONCLUSION
Research on brain stem cell aging within the past decade has
surged and we have made significant advances in understanding
what happens to this cell population in aging and disease using
a variety of in vitro and in vivo model systems. Intrinsic and
extrinsic factors play a large role in the decline of the NSC niche
over time, which can be exacerbated by the disease. These include
DNA damage, changes in metabolism and nutrient sensing, as
well as the chronic pro-inflammatory environment both within
the niche and in systemic fluids, which can all act to maintain
cells in either a quiescent or senescent state, inhibiting their
proper function when needed. These putative markers of NSC
aging may also lead to the identification of biomarkers predictive
for the onset and/or progression of cognitive defects associated
with advancing age and neurodegenerative diseases. For example,
the blood-borne SASP proteins IL-15 and chemokine (C-C
motif) ligand 3 (CCL3) are correlated with chronological age
and cognitive decline (Lehallier et al., 2019; Schafer et al.,
2020). However, the cellular sources of these SASP factors are
currently unknown.
Therefore, using patient-derived NSCs generated from
fibroblasts and profiled for senescence markers may identify the
proportion of circulating proteins contributed by NSCs. Further
study is needed to determine if the NSC senescence burden
in vitro correlates with the development and progression of
cognitive defects in vivo.
There is no single mechanism to aging, andmultiple processes
likely contribute to declining. Therefore, using models in which
we can parse these details is important to understanding the
fundamentals of this process. Interrogating how aging may
differ from diseases associated with aging, both transcriptionally
and proteomically, would allow us to better understand the
discrepancy between those who do and do not develop the
disease, but also identify what facets of aging portend disease.
This includes in vivo models of aging using genetically altered
mice in which certain genes are mutated affecting various
age-associated pathways (i.e., mitochondrial dynamics), allowing
researchers to study in detail how changes alter cellular
and organismal aging. In vitro models using novel stem cell
technologies also hold potential for studying NSC aging in
humans as they retain aging and disease markers. Defining the
mechanisms that trigger modifications in this cell population
with age and in disease will allow for a more directed approach
to developing preventative or curative treatments.
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